The digital health blog

Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.

May 19, 2023

Beyond Patient Engagement: Why Collaboration is Essential in Health Tech

In the recent years, patient engagement has gained great popularity in healthcare. The most impactful and adoptable solutions come from involving patient experts, key opinion leaders and other key stakeholders in a collaborative 'co-creation' process.

Read more
May 12, 2023

Tess’ Top Takes from this Month’s Meetings in Digital Health

Our HealthXL meetings in April covered everything from ‘Data Monetisation for MedTech Companies’ to ‘The Potential of OTC DTx Solutions’. To make sure you’re not missing out on the top insights from our communities, and get a sneak peak at some of the conversations, here are my top five takeaways.

Read more
May 5, 2023

What's standing in the way of more accessible DTx?

DTx solutions have been developed, theoretically, to remove many of the barriers associated with traditional care models and be more scalable and readily available. However, these solutions are not always accessible or inclusive for the populations that could benefit from them the most.

Read more
April 26, 2023

Beyond Pilots: How Can Pharma-DTx Partnerships Scale?

Pharma-DTx partnerships can be a good strategy when both the pharma and the DTx companies speak the same language. While successful pilots have been demonstrated, there are challenges in scaling and sustaining innovations that generate value and return on investment (ROI) for pharma companies.

Read more
April 21, 2023

Tess’ Top Takes from this Month’s Meetings in Digital Health

Our HealthXL meetings in March covered everything from ‘Navigating the DiGA Framework’ to ‘Leveraging Sources of US Government Funding for Digital Health’. Make sure you’re not missing out on the topics that matter the most to our communities and are plugged into the conversation.

Read more
April 14, 2023

Pharma 3.0: Doing Digital Health Better

Over the past decade, pharma’s interaction with digital health has grown more sophisticated and purposeful. In the last year however, innovation wrapped around the drug has become the object of budgetary scrutiny in pharmaceutical companies. So why continue to invest in digital health?

Read more
April 6, 2023

Is There a Space for Digital Health in the World of RNA Based Therapeutics?

In this blog we analyse the current landscape of RNA therapeutics and postulate on where best digital health may support this innovative area of medicine.

Read more
March 31, 2023

Short & Long Term Bets in Digital Health : Key Takeaways from Our Global Gathering in Munich

While the healthtech sector has evolved significantly in the past few years, 2023 looks set to be another year of significant change. At our Global Gathering in Munich, startups, pharma, and investors split up into several roundtables, tackling the several topics. Here is what we learned.

Read more
March 24, 2023

Pear Therapeutics: What Happened and What does this mean for DTx?

Pear Therapeutics announced last week that they are looking into “strategic alternatives” that could bolster its current precarious financial situation. Pear has been on the public markets since late 2021, however, its stock price has declined over the last two years.

Read more
May 19, 2023

Beyond Patient Engagement: Why Collaboration is Essential in Health Tech

In the recent years, patient engagement has gained great popularity in healthcare. The most impactful and adoptable solutions come from involving patient experts, key opinion leaders and other key stakeholders in a collaborative 'co-creation' process.

Read more
May 24, 2023

Tess’ Top Takes from this Month’s Meetings in Digital Health

Our HealthXL meetings in April covered everything from ‘Data Monetisation for MedTech Companies’ to ‘The Potential of OTC DTx Solutions’. To make sure you’re not missing out on the top insights from our communities, and get a sneak peak at some of the conversations, here are my top five takeaways.

Read more
May 5, 2023

What's standing in the way of more accessible DTx?

DTx solutions have been developed, theoretically, to remove many of the barriers associated with traditional care models and be more scalable and readily available. However, these solutions are not always accessible or inclusive for the populations that could benefit from them the most.

Read more
April 26, 2023

Beyond Pilots: How Can Pharma-DTx Partnerships Scale?

Pharma-DTx partnerships can be a good strategy when both the pharma and the DTx companies speak the same language. While successful pilots have been demonstrated, there are challenges in scaling and sustaining innovations that generate value and return on investment (ROI) for pharma companies.

Read more
April 21, 2023

Tess’ Top Takes from this Month’s Meetings in Digital Health

Our HealthXL meetings in March covered everything from ‘Navigating the DiGA Framework’ to ‘Leveraging Sources of US Government Funding for Digital Health’. Make sure you’re not missing out on the topics that matter the most to our communities and are plugged into the conversation.

Read more
April 18, 2023

Pharma 3.0: Doing Digital Health Better

Over the past decade, pharma’s interaction with digital health has grown more sophisticated and purposeful. In the last year however, innovation wrapped around the drug has become the object of budgetary scrutiny in pharmaceutical companies. So why continue to invest in digital health?

Read more
April 6, 2023

Is There a Space for Digital Health in the World of RNA Based Therapeutics?

In this blog we analyse the current landscape of RNA therapeutics and postulate on where best digital health may support this innovative area of medicine.

Read more
April 11, 2023

Short & Long Term Bets in Digital Health : Key Takeaways from Our Global Gathering in Munich

While the healthtech sector has evolved significantly in the past few years, 2023 looks set to be another year of significant change. At our Global Gathering in Munich, startups, pharma, and investors split up into several roundtables, tackling the several topics. Here is what we learned.

Read more